Method and system for consistent, repeatable, and safe cryospray treatment of airway tissue
A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.
1. A computer-moderated method for airway segment-specific and patient type-specific cryo spray treatment of damaged, inflammatory, or hypersecretory airway tissue, comprising the steps of:
receiving, from a user via a cryospray user-interface to a computer console, a patient-type for a patient to be treated;
receiving from the user via the cryospray user-interface, an anatomical airway segment to receive said treatment; and
automatically delivering a pre-determined metered dose of cryospray of cryogen based on said identified patient-type and said identified airway segment, beginning when a user initiates a cryospray treatment, and automatically stopping when the metered dose of cryospray of cryogen has been delivered.
2. A method according to claim 1 , which does not require apposition of a cryospray instrument to said airway tissue.
3. A method according to claim 1 , further comprising receiving a plurality of airway segments to receive the treatment and wherein cryospray doses are automatically set for each of the plurality of the airway segments based on a luminal diameter of the airway segments.
4. A method according to claim 1 , wherein said patient-type is gender, and different cryospray doses are automatically set for male and female patients.
5. A method according to claim 1 , wherein cryospray treatment cannot occur until a user enters the patient-type information and the airway segment for the treatment into the system console.
6. A method according to claim 1 , further comprising maintaining a cryospray supply line between a cryogen tank and a delivery catheter port at a constant temperature during cryospray operation.
7. A method according to claim 6 , wherein one or more of valves, manifold and catheter interface of the cryospray supply line between the cryogen tank and the delivery catheter port is maintained at a constant temperature greater (warmer) than −120° C.
8. A method according to claim 1 , wherein the metered dose of cryospray of cryogen is delivered via a cryogen delivery catheter having a proximal segment that is wider than the working channel of a corresponding bronchoscope, and a distal segment that is configured to fit within the working channel of said bronchoscope, said delivery catheter configured to deliver a cryospray to the entire circumferential interior of a cross-section of the identified airway segment simultaneously without having to rotate the delivery catheter, wherein a distal end of the delivery catheter comprises radial rows of cryogen delivery ports, equally spaced around the perimeter of the delivery catheter, and each port offset from an adjacent port of an adjacent row by 20°-25°.
9. A method according to claim 8 , wherein the distal end of the delivery catheter comprises two rows of eight cryogen delivery ports, the center line of the rows displaced 0.025″ (0.635 mm) from one-another, and each cryogen delivery port is offset from an adjacent port of the other row by 22.5°.
10. A computer-moderated method for cryospray treatment of damaged, inflammatory, or hypersecretory airway tissue, comprising the steps of:
receiving a user input from a user via a cryospray user-interface to a computer console, the user input comprising an identified anatomical airway segment of a patient to receive the cryospray treatment;
calculating, based on the user input and a diameter of the identified anatomical airway segment, an amount of metered cryospray of cryogen to deliver to at least partially ablate the airway tissue of the patient at the identified airway segment; and
automatically delivering the calculated amount of metered cryospray, beginning when the user initiates the cryospray treatment, and automatically stopping when the calculated amount of metered cryospray has been delivered.
11. A method according to claim 10 , wherein the automatically delivering is also based on a temperature input from a cryospray catheter.
12. A method according to claim 11 , wherein automatically stopping occurs when the temperature input indicates that the calculated amount of metered cryospray has been delivered.
13. A method according to claim 11 , wherein automatically stopping occurs prior to the delivery of the calculated amount of metered cryospray if the temperature input is outside of a safety threshold.
14. A method according to claim 10 , wherein the automatic delivering is also based on an energy output from a cryospray catheter.
15. A method according to claim 10 , further comprising receiving a plurality of airway segments to receive the treatment and wherein cryospray doses are automatically set for each of the plurality of the airway segments based on a diameter of the identified anatomical airway segments.
16. A method according to claim 10 , wherein the user input further comprises patient-type information and the cryospray treatment cannot occur until the patient-type information is entered into the system console.
17. A computer-moderated method for cryospray treatment of damaged, inflammatory, or hypersecretory airway tissue, comprising the steps of:
receiving a user input from a user via a cryospray user-interface to a computer console, the user input comprising a patient-type for a patient to be treated;
calculating, based on the user input and a diameter of an airway segment based on the patient type, an amount of metered cryospray of cryogen to deliver to at least partially ablate the airway tissue of the patient; and
automatically delivering the calculated amount of metered cryospray, beginning when the user initiates the cryospray treatment, and automatically stopping when the metered cryospray has been delivered.
18. A method according to claim 17 , wherein the automatically delivering is also based on a temperature input from a cryospray catheter.
19. A method according to claim 17 , wherein the user input further comprises an identified anatomical airway segment of a patient to receive the cryospray treatment, and the calculating is also based on the identified anatomical airway segment.
20. A method according to claim 19 , wherein the user input further comprises a plurality of identified airway segments and wherein cryospray doses are automatically set for each of the plurality of the airway segments based on a diameter of the airway segments.